Stay updated on Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.

Latest updates to the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedFooter and navigation content updated with revision information (v3.6.6), release notes, and a Study Protocol/SAP PDF reference; these additions are global site elements rather than changes to the study details themselves.SummaryDifference100%

- Check16 days agoChange DetectedThe page shows a new revision tag, updating from v3.6.5 to v3.6.6, indicating a small backend or content update to the page. This update does not modify the study details or other user-facing information.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5. This indicates a minor update to the page’s revision metadata rather than substantive content changes.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a minor site version update. This change reflects maintenance of the page version rather than any modification to trial content or functionality.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2. This reflects a minor maintenance update to the page without changes to the study information or its presentation.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page's revision tag is updated to v3.6.2, reflecting a new version. The previous v3.6.0 tag was removed.SummaryDifference0.1%

Stay in the know with updates to Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.